Abstract:Previous evidence demonstrated the antitumor ability of quinazolines and its derivatives. In this study, the anticancer activities of N-(4-chlorophenyl)-5,6,7-trimethoxyquinazolin-4-amine dihydrochloride against four kinds of cell lines were evaluated by 3-(4,5-dimeth-ylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. The bioassay results indicated that title compound possessed wide spectrum of anticancer activity. Androgen-independent prostate cancer (PC-3) cells were employed and microscopic observation, lactate dehydrogenase (LDH) release assay, and Western blot were performed to study the antitumor mechanism of N-(4-chlorophenyl)-5,6,7-trimethoxyquinazolin-4-amine dihydrochloride against tumor cells. It was found that title compound executed anticancer activity in a dose-dependent manner with 24.46 mu M IC50 of 72 h treatment. Microscopic observation and LDH release assay showed that the compound exerted such an effect through antiproliferation pathway rather than cytotoxicity. Furthermore, Western blot analysis revealed that treatment of cells with N-(4-chlorophenyl)-5,6,7-trimethoxyquinazolin-4-amine dihydrochloride (at more than 10 mu M for 30 min) resulted in an almost complete inhibition of epidermal growth factor (EGF) induced phosphorylation of extracellular signal-regulated protein kinase1/2 (ERK1/2) which suggests that its antiproliferation effect is linked to its inhibition of ERK1/2 activation. These data imply that N-(4-chlorophenyl)-5,6,7-trimethoxyquinazolin-4-amine dihydrochloride is a potential anticancer agent capable of antiproliferation activity.

Anti-Tumour Activity of 4-(4-fluorophenyl)amino-5,6,7-trimethoxyquinazoline Against Tumour Cells in Vitro

Antitumor Effect of N-(4-Chlorophenyl)-5,6,7-Trimethoxyquinazolin-4-Amine Dihydrochloride on Tumor Cells in Vitro

Synthesis and Antitumor Activity of Novel 4-Aminoquinazoline Derivatives Containing Benzothiazole

Synthesis and Anti‐Proliferation Activity Evaluation of Novel 2‐chloroquinazoline As Potential EGFR‐TK Inhibitors

Synthesis and Anticancer Activities of 5,6,7-Trimethoxy-n-phenyl(ethyl)-4-aminoquinazoline Derivatives

Design, synthesis and anti-tumor activity evaluation of 4,6,7-substitute quinazoline derivatives

Synthesis and antitumor activity evaluation in vitro of 4-aminoquinazoline derivatives containing 1,3,4-thiadiazole

Design, synthesis and biological evaluation of novel 2,4-disubstituted quinazoline derivatives targeting H1975 cells via EGFR-PI3K signaling pathway

Synthesis and anticancer activities of 4-(4-substituted piperazin)-5,6,7-trialkoxy quinazoline derivatives

Synthesis and Antiproliferative Activity of 6,7-Disubstituted-4-phenoxyquinoline Derivatives Bearing the 2-Oxo-4-chloro-1,2-dihydroquinoline-3-carboxamide Moiety.

Synthesis, in Vitro and in Vivo Evaluation of Novel Substituted N-(4-(2-(4-benzylpiperazin-1-yl)ethoxy)phenyl)-N-methyl-quinazolin-4-amines As Potent Antitumor Agents.

Design, Synthesis and Antitumor Activity Evaluation of 4,6,7-Trisubstituted Quinazoline Derivatives Containing Benzothiazole Moiety

Synthesis and Antitumor Activity of 2,4,6-Trisubstituted Novel Quinazoline Derivatives Containing Trifluoromethyl

Design, Synthesis and Biological Evaluation of Novel 2,4,6-Trisubstituted Quinazoline Derivatives As Potential Antitumor Agents

Synthesis and Antitumor Activity Evaluation of 2,4,6-Trisubstituted Quinazoline Derivatives Containing Thiazole Structure

Synthesis and Antitumor Activity of Novel 6,7,8-Trimethoxy N-aryl-substituted-4-aminoquinazoline Derivatives.

Novel 5-Methyl-2-[(un)substituted Phenyl]-4-{4,5-Dihydro-3-[(Un)Substituted Phenyl]-5-(1,2,3,4-Tetrahydroisoquinoline-2-Yl)Pyrazol-1-Yl}-Oxazole Derivatives: Synthesis and Anticancer Activity

Synthesis and preliminary structure-activity relationship study of 3-methylquinazolinone derivatives as EGFR inhibitors with enhanced antiproliferative activities against tumour cells

Identification of (S)-1-(2-(2,4-difluorophenyl)-4-oxothiazolidin-3-yl)-3-(4-((7-(3-(4-ethylpiperazin-1-yl)propoxy)-6-methoxyquinolin-4-yl)oxy)-3,5-difluorophenyl)urea as a potential anti-colorectal cancer agent

Synthesis, anticancer evaluation and mechanism studies of novel indolequinone derivatives of ursolic acid

Novel 4-arylaminoquinazolines bearing N , N -diethyl(aminoethyl)amino moiety with antitumour activity as EGFR wt -TK inhibitor.